Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,172.64, giving the company a market capitalization of 1.1T. It carries a P/E multiple of 39.58 and pays a dividend yield of 0.57%.
On 2026-09-22, Eli Lilly(LLY) stock traded between a low of $1,139.33 and a high of $1,180.47. Shares are currently priced at $1,172.64, which is +2.9% above the low and -0.7% below the high.
The Eli Lilly(LLY)'s current trading volume is 2.45M, compared to an average daily volume of 2.27M.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
LLY News
In some ways, Novo Nordisk (NVO -1.00%) clearly has an image problem. It effectively created the GLP-1 weight-loss drug market when it launched Wegovy. But it q...
Nektar Therapeutics (NKTR) quickly sank 11% as a jury deliberated in its patent dispute with Eli Lilly (LLY) over its Rezpeg drug. The jury in San Francisco fe...
The U.S. Food and Drug Administration (FDA) on Friday granted full approval to Eli Lilly and Co.’s (NYSE:LLY) Inluriyo (imlunestrant) in combination with Verzen...
Analyst ratings
84%
of 32 ratingsMore LLY News
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The study, officially titled A Study to Investigate the Safety, Tolerability,...
Key Points Eli Lilly's yield of 0.6% looks minimal, but that's only because of how incredibly well the stock has performed. Pfizer has one of the highest yiel...
Eli Lilly and Co.‘s (NYSE:LLY) CEO Dave Ricks announced a significant increase in the use of GLP-1 treatments among seniors, following Medicare’s July decision...
Technology Viking Therapeutics Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall. Licensing Viking Therapeutics and Roche both reported positive trial data...
Investing Eli Lilly’s Tough Month: One of The Biggest Global Banks Says 37% Gains Begin Soon Eli Lilly just posted a quarter that crushed estimates on every maj...
TD Cowen analyst Steve Scala maintained a Buy rating on Eli Lilly & Co today and set a price target of $1,250.00. Steve Scala has given his Buy rating due to a...
Eli Lilly (NVO) CEO David Ricks said he is optimistic that the drugmaker's oral weight loss pill Foundayo (orforglipron) will continue to increase its market sh...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.